5-Bromo-2-chlorobenzoic acid is used as a starting material in the synthesis of Dapagliflozin (D185370), a selective sodium-glucose cotransporter-2 inhibitor that reduces renal glucose reabsorption and is used to treat patients with type 2 diabetes. Mole
Molecular Weight:
235.46
Form:
Supplied as a White Solid
CAS Number:
[21739-92-4]
* VAT and and shipping costs not included. Errors and price changes excepted